United Services Automobile Association Coherus Bio Sciences, Inc. Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$16.3 - $23.37 $3.54 Million - $5.08 Million	-217,216 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$13.1 - $22.1 $25,545 - $43,095	1,950 Added 0.91%	217,216 $4.8 Million
Q4 2018 Feb 13, 2019	SELL	$8.65 - $16.28 $134,334 - $252,828	-15,530 Reduced 6.73%	215,266 $1.95 Million
Q3 2018 Nov 13, 2018	SELL	$14.45 - $20.25 $83,347 - $116,802	-5,768 Reduced 2.44%	230,796 $3.81 Million
Q2 2018 Aug 10, 2018	SELL	$10.25 - $17.45 $24,159 - $41,129	-2,357 Reduced 0.99%	236,564 $3.31 Million
Q1 2018 May 14, 2018	BUY	$9.1 - $13.7 $56,301 - $84,761	6,187 Added 2.66%	238,921 $2.64 Million
Q4 2017 Feb 14, 2018	BUY	$8.35 - $14.4 $412,840 - $711,964	49,442 Added 26.97%	232,734 $2.05 Million
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $2.03 Million - $2.66 Million	183,292	183,292 $2.45 Million

133

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.